Role of Cerebroplacental Ratio Discordance at 16-20 Weeks in Predicting Monochorionic Twin Pregnancies' Specific Complications

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorAin Shams Maternity Hospital

About this trial

The purpose of this study is to evaluate the predictive value of CPR discordance at 16-20 weeks in MCDA twin pregnancies in predicting monochorionic-specific complications such as TTTS, TAPS, sFGR and IUFD of one or both fetuses

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 18 years or more and able to consent.

Monochorionic Diamniotic twin pregnancy.

Discordant inter-twin cerebroplacental ratio at 16-20 weeks of gestation.

Disqualifiers

Fetal structural malformations or chromosomal abnormalities in any of the twins as detected by anomaly scan antenatally or neonatal examination postnatally (chromosomal abnormalities and some congenital malformations can interfere with normal fetal growth).

Identified infectious etiologies detected during immediate postnatal examination or during pregnancy (fetal infections can cause FGR ,usually symmetric type particularly if they occur in early gestation).

Referral after development of Twin to twin transfusion syndrome, twin anemia polycythemia sequence or selective fetal growth restriction.

Single fetal demise at the time enrollment in the study.

Trial population

Monochorionic diamniotic twin pregnancies with discordant cerebroplacental ratio at 16-20 weeks of gestation presenting to Ain Shams University Maternity Hospital for antenatal care.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Ultrasound

    Device

    Measuring cerebroplacental ratio discordance in monochorionic twins at 16-20 Weeks of gestation

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Development of monochorionic specific complications

Monochorionic specific complications include twin to twin transfusion syndrome, twin anemia polycythemia sequence and selective fetal growth restriction

Time frame
From 16-20 weeks of gestation till delivery.

Secondary outcomes

1

Occurrence of intrauterine fetal death or perinatal mortality of one or both fetuses

Gestational age upon occurrence of IUFD with clarifying if complications occur in the surviving twin in case of single fetal demise. Time and reason of perinatal mortality for any of the fetuses Wil be recorded.

Time frame
From 16-20 weeks of gestation till 7th day of life

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.